Metastatic Liver Cancer Clinical Trial
Official title:
Phase I Study of Capecitabine in Combination With SIR-Spheres in Patients With Advanced Cancer
This trial is testing the safety of combining the oral chemotherapy drug capecitabine with radio-labeled microspheres injected directly into the liver.
Patients with adequate liver function and performance status in whom liver-directed therapy and capecitabine would be appropriate are eligible for this clinical trial. ;
Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04970212 -
Safety and Effectiveness of BioTraceIO Lite for Tissue Damage Assessment Following Liver Tissue Ablation Procedures
|
||
| Recruiting |
NCT04616495 -
Liver Transplantation in Patients With Unresectable Colorectal Liver Metastases
|
||
| Terminated |
NCT03349255 -
Clinical Study of ET1402L1-CAR T Cells in AFP Expressing Hepatocellular Carcinoma
|
Phase 1 | |
| Completed |
NCT02201797 -
Reproducibility and Repeatability of Multifunctional MRI Biomarkers of the Body
|
N/A | |
| Recruiting |
NCT03965546 -
ET 140202 -T Cell Combined With TAE or Sorafenib in the Treatment of Liver Cancer
|
Early Phase 1 | |
| Terminated |
NCT03998033 -
Study of ET140202 T Cells in Adults With Advanced Hepatocellular Carcinoma
|
Phase 1 | |
| Not yet recruiting |
NCT04825470 -
Liver Transplantation for Unresectable GIST Liver Metastases
|
N/A | |
| Recruiting |
NCT04864054 -
T-Cell Therapy (ECT204) in Adults With Advanced HCC
|
Phase 2 | |
| Recruiting |
NCT05913141 -
PDO/PDO-TIL/PDOTS for Drug Screen
|
||
| Not yet recruiting |
NCT05582018 -
Safety and Effectiveness of BioTraceIO 360 for Planning, Monitoring and Assessment of Liver Tissue Ablation Procedures
|
N/A | |
| Recruiting |
NCT01895010 -
Acupoint Electric Stimulation Combined With Tropisetron in Preventing and Treating Nausea and Vomiting After TACE
|
Phase 2 | |
| Withdrawn |
NCT05641922 -
Safety and Effectiveness of BioTraceIO 360 for Planning, Monitoring and Assessment of Liver Tissue Ablation Procedures (PANORAMA2)
|
N/A | |
| Recruiting |
NCT04634357 -
ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma
|
Phase 1/Phase 2 | |
| Recruiting |
NCT04708483 -
DCE-CT of Thoracic Tumors as an Early Biomarker for Treatment Monitoring in Comparison With Morphologic Criteria
|
N/A | |
| Terminated |
NCT02787954 -
Prospective Tumor Response Evaluation
|
||
| Completed |
NCT04513457 -
Chemotherapy for Resectable Colorectal Liver Metastases
|
||
| Recruiting |
NCT01442324 -
Pilot Study of Irreversible Electroporation (IRE) to Treat Metastatic Liver Cancer & Cholangiocarcinoma
|
N/A | |
| Completed |
NCT03888859 -
ET1402L1-ARTEMIS™2 T Cells in Alpha Fetoprotein (AFP) Expressing Hepatocellular Carcinoma
|
Early Phase 1 | |
| Not yet recruiting |
NCT05643417 -
Camrelizumab Combined With Bevacizumab and HAIC in Patients With Metastatic Liver Cancer Who Failed Standard Therapy
|
Phase 1 | |
| Recruiting |
NCT05240950 -
Anti-CEA CAR-T Cells to Treat Colorectal Liver Metastases
|
Phase 1 |